Artificial Intelligence Technology Solutions Inc (AITX): Reflections on the path to profitability...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Artificial Intelligence Technology Solutions Inc (AITX)

Reply Private New

Keep Last Read

Replies (11) Next 10 Prev Next

Send PM Follow Ignore

Followers	27
Posts	7344
Boards Moderated	3
Alias Born	03/20/2017

Re: ZenElf84 post# 63498

Wednesday, 04/23/2025 11:19:41 PM

Wednesday, April 23, 2025 11:19:41 PM

Reflections on the path to profitability: all IMO and thoughts, be advised this is not investment advice. The company is yet to develop further momentum for profit, NOTE its latest quarterly report signifies consistent growth towards that.

While a number of factors is not in the control of AITX (external outside factors such as geopolitical and macroeconomic for example), the management team is stepping up its game to close the gap to reach profitability.

We as shareholders can assist the company, as we are all part owners. Comment on stock boards in a constructive and positive way. Spread the word, as it`s in our own interest to show the market we actively support AITX.

Latest updates: https://aitx.ai/

Bullish

Keep Last Read

Replies (11) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent AITX News

Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 07:57:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 10:01:43 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/26/2025 04:15:20 AM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/20/2025 01:31:10 PM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 06/18/2025 06:41:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2025 10:01:54 AM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 06/17/2025 09:03:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2025 09:00:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2025 02:02:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 08:00:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/09/2025 10:02:52 AM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/06/2025 08:55:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 10:01:55 AM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/03/2025 09:19:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/02/2025 10:02:57 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 10:02:44 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/29/2025 09:26:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2025 07:59:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 10:01:22 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 10:01:28 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 10:01:17 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 10:04:48 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 10:01:20 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 10:06:05 AM

More AITX News

InvestorsHub NewsWire

Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM

Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM

Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow